Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2023

Every FDA drug recall initiated in 2023, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,122 recalls, newest first.

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0400-1 D-0682-2023
Class II · Moderate risk

Modified del Nido Microplegia

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0219-1 D-0681-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0218-1 D-0680-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0215-1 D-0679-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0214-1 D-0678-2023
Class II · Moderate risk

Microplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0213-1 D-0677-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0212-1 D-0676-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0211-1 D-0675-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0210-1 D-0674-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0209-1 D-0673-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0206-1 D-0672-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0205-1 D-0671-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0204-1 D-0670-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0203-1 D-0669-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0202-1 D-0668-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0112-1 D-0667-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0111-1 D-0666-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0107-1 D-0665-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0106-1 D-0664-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0105-1 D-0663-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0104-1 D-0662-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0103-1 D-0661-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0102-1 D-0660-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0101-1 D-0659-2023
Class II · Moderate risk

Cardioplegia Solution

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0100-1 D-0658-2023

Recalls by year